Addex Therapeutics Equity Research Report Update Issued by valuationLAB

Addex and Indivior Sign Strategic Partnership to Accelerate Development of GABAB PAMs as Addiction Treatments

Van Leeuwenhoeck Issues Initiation of Coverage Research Report on Addex Therapeutics and Estimated ADXN Share Price of CHF 11.5 per Share

Addex Therapeutics ADX71441 Program Awarded $5.3 Million Grant from US National Institute on Drug Abuse to Support Human Studies for the Treatment of Cocaine Use Disorder

Addex Therapeutics Reports First Half 2017 Operating Highlights and Financial Results

Addex Makes Changes to Executive Management

Addex Shareholders Approved all Board Proposals at 2017 Annual General Meeting

Addex Annual General Meeting Scheduled for 22 June 2017

Addex Increases Issued Share Capital and Creates Treasury Shares

Addex ADX71441 Demonstrates Preclinical Analgesic Effects